Funded Tech Companies
Abcuro
Abcuro is a biopharmaceutical company, based in Newton. VC investment was provided by BlackRock, Soleus Capital and New Leaf Venture Partners.
Company Overview
Company Name
Abcuro
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
90 Bridge St. 100
Newton, MA 02458
USA
Newton, MA 02458
USA
Phone
Website
Email Address
Company Background Information
Overview
We are developing first-in-class immunotherapies for autoimmune diseases and cancer through precise elimination or modulation of cytotoxic T and NK cells via KLRG1. We believe this strategy will result in therapeutics with reduced toxicity compared to existing therapeutic approaches for T cell modulation.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/13/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Steven Greenberg
Chief Executive Officer
David de Graaf
Chief Financial Officer
David Neafus
Chief Medical Officer
Richard Polisson
Chief Operating Officer
Evan Thompson
Chief Scientific Officer
Stefano Gulla
Company Investors
- BlackRock
- Soleus Capital
- New Leaf Venture Partners
- Abrdn
- Sanofi Ventures
- Mass General Brigham Ventures
- RA Capital Management
- New Enterprise Associates
- Foresite Capital
- Bain Capital Life Sciences
- Samsara BioCapital (Donald McCarthy)
- Pontifax Venture Capital
- Eurofarma
- Redmile Group
- Tekla Capital Management
- Sanofi-Genzyme BioVentures (Jason Hafler)
- Pontifax Fund (Iyona Rajkomar)
- Hongsen Investment (Yajun Xu)
- RA Capital (Ryan Berry)
- Mass General Brigham Innovation (Julius Knowles)
Browse more funded tech companies:
abCoffee | Abdera Therapeutics
Share this article
About Our VC Deals Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs